Valunova Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.30 Cr
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -55.72%
- Profit Growth -12.23%
- Ebitda -97.49%
- Net Worth -2.77%
- Total Assets -2.57%
About Valunova Lifesciences
Valunova Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 July 2020 (Four years and seven months 24 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Valunova Plastpack Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anilkumar Khemka and Nishu Agrawal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100GJ2020PTC114270
- Company No.
114270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Valunova Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishu Agrawal  | Director | 01-Jul-2020 | Current |
| Anilkumar Khemka | Director | 01-Jul-2020 | Current |
Financial Performance of Valunova Lifesciences.
Valunova Lifesciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 55.72% decrease. The company also saw a substantial fall in profitability, with a 12.23% decrease in profit. The company's net worth dipped by a decrease of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valunova Lifesciences?
In 2022, Valunova Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anikem Laboratories Private LimitedAnilkumar Khemka is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Valunova Lifesciences?
Valunova Lifesciences has a workforce of 36 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valunova Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valunova Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.